Notice of Extension of the Expiration Date "Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)"
National Institutes of Health (NIH)
About this archived opportunity
November 18, 2024 - Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional). See NOFO PAR-25-111. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) The purpose of this Notice is to inform applicants that Eunice Kennedy Shriver National Institute for Child Health and Human Development (NICHD) is extending the expiration date for PAR-25-111, Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) by one Application Due Date. Therefore, with the addition/extension by one Application Due Date, PAR-25-111 now expires on July 07, 2026. The following sections in Part 1. Overview Information, Key Dates section have been changed: Obstetric and Pediatric Pharmacology and Therapeutics Branch (OPPTB) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Historical details
- Status
- Closed
- Deadline
- May 8, 2026
- First captured
- June 6, 2026
- Publisher reference
- http://grants.nih.gov/grants/guide/notice-files/NOT-HD-26-003.html
This opportunity has closed
Notice of Extension of the Expiration Date "Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)"
by National Institutes of Health (NIH)
Get notified when similar opportunities open
We'll save this search and email you when new extension, expiration, date opportunities are posted. Free.